Pre-Analytical Discipline for Field Reliability: Volumes, Dilutions, and Matrix Choice per IFU

Acceptable Matrices & Why They Matter

 Serum, Plasma (EDTA/Heparin/Citrate), Whole Blood

• Serum. Coagulated blood; absence of fibrin can reduce matrix interference in some immunoassays. See fundamentals of specimen types in clinical chemistry curricula at UCSF, UMich, and sample processing primers from CDC and NIH.

• Plasma. Anticoagulated; anticoagulant choice affects ionic strength and protein interactions. EDTA can chelate metal-dependent epitopes; citrate dilutes plasma; heparin may interact with certain proteins. Review anticoagulant effects in teaching resources from NCSU, UT Austin, and general assay chemistry notes at NIST.

• Whole Blood. Highest matrix complexity; cellular components can scatter light or bind dyes. Pre-analytical interferences overview: CDC – Laboratory Best Practices, USDA NVSL – sample handling for veterinary testing, and biosafety reminders from OSHA.

Rule: Only load matrices explicitly allowed in the product IFU. If matrix not listed, do not test; route to a validated laboratory pathway. See regulatory basics on IFU adherence at FDA and validation primers via NIH NLM.

Exact Volumes & Required Dilutions (Follow IFU)

 Typical IFU-Driven Workflows by Well Type

The example below illustrates how distinct wells dictate different sample-prep steps. Always replace with the exact values from your device’s IFU.

• CHW (Chromogenic/Colorimetric Hemato-Well) path (example):
  Pipette 10 µL neat sample directly to CHW, then add Buffer A per IFU. Mix gently without bubbling.
  Pipetting accuracy and precision: see microliter technique guides from NIH OITE, MIT OpenCourseWare – experimental techniques, and volumetric accuracy notes at NIST.

• EHR/ANA/BAB wells (example):
  Combine 20 µL sample with EHR-ANA-BAB buffer (ratio per IFU, e.g., 1:4), mix, then load the mixture into the designated wells.
  Fundamentals of dilution arithmetic and uncertainty: NIST SI Education, university lab math refreshers at Stanford and Harvard.

Non-negotiables

• Use calibrated pipettes (ISO-traceable or equivalent). See metrology best practices at NIST.

• Change tips between samples to prevent carryover (biosafety basics at CDC).

• Verify dilution recipe (C1V1=C2V2) in writing; keep a printed quick-reference card (good manufacturing hygiene per FDA).

Temperature Equilibration, Read Window, Light & Stability

 Equilibrate All Components to 15–25 °C

• Bring cartridges, buffers, and samples to room temperature for the time specified in the IFU (common: 15–30 min). Cold reagents slow binding kinetics; warm reagents accelerate background.
  Rationale and kinetics primers: NIH – Basic Science of Binding, NIST – chemical kinetics references.
  Field reality checks for transport and ambient variation: USDA APHIS field guidance, EPA – temperature control during sampling.

 Strict Read Window (e.g., 5–10 min)

• Start a timer upon loading. Read only in the IFU-specified interval. Early reads under-develop; late reads may drift or over-develop (esp. enzyme-mediated signals).
  Timing discipline and human-factors reminders: CDC – CLIA Waived Testing Good Practices, academic notes on assay kinetics at UCLA.

 Storage Stability & Light Exposure

• Storage range: keep kits 2–30 °C (example envelope) without freezing unless IFU states otherwise. Freezing may precipitate salts or denature proteins.
  See reagent stability fundamentals at NIH NLM Bookshelf, cold-chain basics from CDC Vaccine Storage & Handling, and photodegradation primers at NIST.

• Light protection: Many dyes are photo-labile. Store in original foil or amber containers; minimize bench light. Environmental light effects background reading; see EPA – light and photolysis, and spectroscopy notes at Berkeley and Caltech.

Field-Ready SOPs for CHW vs EHR/ANA/BAB

 CHW Path — Example SOP

1. Verify lot and expiry on cartridge & buffer (Section 6).

2. Equilibrate to 15–25 °C.

3. Label device and sample clearly (avoid swap; identity controls per CDC).

4. Pipette 10 µL sample → CHW well.

5. Add Buffer A per IFU drops/µL.

6. Start timer; develop and read at 5–10 min window.

7. Record result, operator ID, temperature, and any deviations (data integrity primers at FDA).

 EHR/ANA/BAB Path — Example SOP

1. Bring sample + EHR-ANA-BAB buffer to 15–25 °C.

2. Mix 20 µL sample with buffer to the IFU ratio.

3. Load the mixture into EHR, ANA, BAB wells as directed.

4. Tap gently to release bubbles (optical interference basics at NIST).

5. Read in the IFU window; document.

Tip: Pre-print bench cards with: allowed matrices, volume(s), buffer ratio, and read window. Keep with the kit and laminate (field durability).

Declaring an Invalid Test (Fail-Safe Criteria)

Declare the run invalid and repeat with a fresh device (new lot component set) if any applies:

• Sample matrix not specifically permitted in the IFU.

• Volume or dilution deviated from IFU (wrong µL, wrong ratio).

• Components not within 15–25 °C at the moment of loading.

• Read window missed (too early/late).

• Storage outside allowable range, freeze exposure when prohibited, or light over-exposure of light-sensitive reagents.

• Mixed lots in one run (see Section 6).

• Controls (internal/external) fail acceptance. External controls guidance: CDC, CLIA waived testing basics at CDC CLIA, general quality systems overviews at FDA.

Lot Integrity: Never Mix Components Across Lots

• Each disposable device and its buffers are lot-matched. Do not combine a cartridge from Lot A with a buffer from Lot B.

• Log the lot, expiry, storage temp, and operator for every run (data traceability: FDA, measurement traceability: NIST.

• Quarantine any damaged foil pouches or labels. Return to supplier per RMA practice (see general handling expectations on GSA and bio-logistics at USDA).

Environmental & Biosafety Controls (POC Reality)

• Biosafety: Follow standard precautions (gloves, eye protection, sharps). References: CDC/NIOSH bloodborne pathogens, OSHA.

• Surface & timing control: Use a flat, vibration-free surface; avoid drafts or direct sun. Environmental sampling control ideas: EPA.

• Waste: Dispose per local biomedical waste rules; overview frameworks at EPA RCRA and state university EH&S pages like UW or UC.

Documentation Pack (What to Record Every Time)

Minimum record set (paper or LIMS):

• Operator ID, date/time, ambient temperature (or device onboard reading).

• Device lot/expiry, buffer lot/expiry.

• Sample matrix, volume, dilution recipe.

• Time loaded and time read (confirm within window).

• Control results and final call.
  Data integrity & ALCOA+ principles references: FDA, data stewardship primers at NLM, and QA frameworks at NIST.

Training & Competency (Keep It Simple, Keep It the Same)

• Train to the bench card (matrix → volume → buffer ratio → read window → invalid rules).

• Annual competency with blinded specimens; see proficiency testing concepts at CDC.

• Keep a single canonical SOP; version control it (university SOP templates: UNC, Penn State).

Field Checklist (Turn into a Sticker Near the Reader)

Before opening pouch

• ☐ Confirm IFU-allowed matrix (serum / plasma type / whole blood).

• ☐ Verify lot/expiry on cartridge and buffer (no cross-lot mixing).

• ☐ Confirm storage history within 2–30 °C, no freeze, minimal light.

Setup

• ☐ Equilibrate everything to 15–25 °C (note ambient).

• ☐ Pre-label test and controls; prepare timer.

• ☐ Review bench card for volume and dilution.

Run

• ☐ Pipette exact µL; prepare correct dilution.

• ☐ Load per CHW or EHR/ANA/BAB SOP.

• ☐ Start timer; read only within 5–10 min (per IFU).

After

• ☐ Record result, timepoints, lots, operator.

• ☐ If any deviation → declare INVALID and repeat with fresh kit.

• ☐ Dispose waste per local EH&S (EPA, university EH&S examples: UCSB).

Figures (Ready-to-Draw Specifications)

Figure 1. CHW Workflow (Annotated).
Panels A–E with callouts:

• A: Confirm matrix & lots → 2–30 °C storage icon → no freeze icon.

• B: Equilibrate to 15–25 °C (thermometer icon, 20 min).

• C: Pipette 10 µL sample → CHW well; add Buffer A (drop counter).

• D: Start timer → read at 5–10 min window (green zone).

• E: Log lots, temperature, and final call; invalid flag if rules broken.

Figure 2. EHR/ANA/BAB Workflow (Annotated).
Panels A–F:

• A: Same storage & lot checks.

• B: Equilibrate components.

• C: 20 µL sample + buffer at IFU ratio (1:4 example), swirl mix.

• D: Load mixture to EHR, ANA, BAB wells; bubble warning.

• E: Timer + read window.

• F: Documentation; invalid criteria list.

Figure 3. Storage/Handling Checklist Infographic.
Left column: Temperature bands (2–30 °C storage; 15–25 °C run).
Center: Light shield icons; Do Not Freeze symbol.
Right: Lot-matching link icons; No cross-lot sign; Controls pass/fail.

SEO-Ready Metadata & Internal Linking Suggestions

• Title tag (≤60 chars): Pre-Analytical Discipline: Matrices, Volumes & Dilutions

• Meta description (≤155 chars): Field-ready SOP for matrices, volumes, dilutions, temperature, read windows, and lot integrity to protect POC accuracy per IFU.

• H1/H2 structure: Mirror the sections above; include “per IFU”, “read window”, “lot integrity”, “matrix effects”, “temperature equilibration”.

• Internal links (examples):

  • Link from your Vet-Diagnostix page sections that mention sample handling to this guide (e.g., “See Pre-Analytical Discipline Guide for volumes and matrices per IFU”).

  • Cross-link to your product IFU download pages and external QC/control products.

Quick “Do/Don’t” Table for Field Teams

---

Supplier & IFU Access

For product-specific IFUs, instructions, and training materials, consult the manufacturer’s site (e.g., vet-diagnostix.com), and archive a local PDF copy in your LIMS. Align your internal bench cards with exact IFU text.